BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23661105)

  • 1. EpiDOCK: a molecular docking-based tool for MHC class II binding prediction.
    Atanasova M; Patronov A; Dimitrov I; Flower DR; Doytchinova I
    Protein Eng Des Sel; 2013 Oct; 26(10):631-4. PubMed ID: 23661105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpiTOP--a proteochemometric tool for MHC class II binding prediction.
    Dimitrov I; Garnev P; Flower DR; Doytchinova I
    Bioinformatics; 2010 Aug; 26(16):2066-8. PubMed ID: 20576624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships.
    Hattotuwagama CK; Doytchinova IA; Flower DR
    Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of an epitope prediction tool for swine (PigMatrix) based on the pocket profile method.
    Gutiérrez AH; Martin WD; Bailey-Kellogg C; Terry F; Moise L; De Groot AS
    BMC Bioinformatics; 2015 Sep; 16():290. PubMed ID: 26370412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties.
    Cui J; Han LY; Lin HH; Tang ZQ; Jiang L; Cao ZW; Chen YZ
    Immunogenetics; 2006 Aug; 58(8):607-13. PubMed ID: 16832638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based identification of MHC binding peptides: Benchmarking of prediction accuracy.
    Kumar N; Mohanty D
    Mol Biosyst; 2010 Dec; 6(12):2508-20. PubMed ID: 20953500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cohesive and Integrated Platform for Immunogenicity Prediction.
    Dimitrov I; Atanasova M; Patronov A; Flower DR; Doytchinova I
    Methods Mol Biol; 2016; 1404():761-770. PubMed ID: 27076336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
    Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
    J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II HLA-peptide binding prediction using structural principles.
    Mohanapriya A; Lulu S; Kayathri R; Kangueane P
    Hum Immunol; 2009 Mar; 70(3):159-69. PubMed ID: 19187794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarity between segments in protein conformational epitopes and MHC II peptides.
    Li G; Wu D; Wang S; Sun J; Xu D; Cao Z
    Int J Comput Biol Drug Des; 2013; 6(1-2):107-18. PubMed ID: 23428477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico designing breast cancer peptide vaccine for binding to MHC class I and II: A molecular docking study.
    Mahdavi M; Moreau V
    Comput Biol Chem; 2016 Dec; 65():110-116. PubMed ID: 27816827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.
    Andreatta M; Karosiene E; Rasmussen M; Stryhn A; Buus S; Nielsen M
    Immunogenetics; 2015 Nov; 67(11-12):641-50. PubMed ID: 26416257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of machine learning techniques in predicting MHC binders.
    Lata S; Bhasin M; Raghava GP
    Methods Mol Biol; 2007; 409():201-15. PubMed ID: 18450002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of MHC-binding peptides of flexible lengths from sequence-derived structural and physicochemical properties.
    Cui J; Han LY; Lin HH; Zhang HL; Tang ZQ; Zheng CJ; Cao ZW; Chen YZ
    Mol Immunol; 2007 Feb; 44(5):866-77. PubMed ID: 16806474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of different generic in silico methods for predicting HLA class I binding peptide vaccine candidates using a reverse approach.
    Gowthaman U; Chodisetti SB; Parihar P; Agrewala JN
    Amino Acids; 2010 Nov; 39(5):1333-42. PubMed ID: 20379752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC Class II Binding Prediction by Molecular Docking.
    Atanasova M; Dimitrov I; Flower DR; Doytchinova I
    Mol Inform; 2011 Apr; 30(4):368-75. PubMed ID: 27466953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions.
    Xu Y; Luo C; Qian M; Huang X; Zhu S
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S9. PubMed ID: 25521198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes.
    Bordner AJ
    PLoS One; 2010 Dec; 5(12):e14383. PubMed ID: 21187956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression.
    Doytchinova IA; Flower DR
    J Chem Inf Model; 2007; 47(1):234-8. PubMed ID: 17238269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes.
    Bhasin M; Raghava GP
    J Biosci; 2007 Jan; 32(1):31-42. PubMed ID: 17426378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.